Case details

Print
Merger control
Case reference
Ccent/2025/21 - Cencora / Alloga Logifarma
Acquired
Alloga Logifarma, S.A.
Description
Portuguese company with prewholesaling activity, which provides storage and logistics services to the pharmaceutical industry before pharmaceutical products enter the wholesale and retail distribution chains.
Acquiring
Cencora Unipessoal, Lda.
Description
Portuguese company whose purpose is to provide consultancy and management services, and purchase, sale and rental of properties. It is part of the Cencora Group, which is dedicated to pharmaceutical supply and distribution, specializing in (i) providing logistics services, mainly to pharmaceutical manufacturers, clinical research organizations and contract development and product manufacturing organizations, (ii) providing various services to pharmaceutical manufacturers in relation to commercial pharmaceutical products, (iii) acquiring private label generic products and (iv) providing support services to independent pharmacies.
Sector
  • Health & Pharmaceutical
Activity (NACE)
  • G4646 - Wholesale of pharmaceutical goods
Applicable legislation
Art. 37(1)(c) (Law 19)
Notification thresholds
Turnover threshold
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

The concentration operation consists of the acquisition, by Cencora, Unipessoal, Lda. (“Cencora”) of exclusive control over Alloga Logifarma, S.A.

Timeline
Click here to see your activities